Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacteriology
Researchers discover Plectasin effective on resistant bacterial infections
November 18th, 2005
Novozymes has discovered Plectasin, an antimicrobial peptide (AMP) that acts on bacterial infections that have developed resistance to conventional antibiotics. Plectasin is not only as effective as traditional antibiotics, it also acts on bacterial infections that have developed resistance to existing types of antibiotic. It also acts on bacteria responsible for a disease like pneumonia. The results have been published in the October 13, 2005 issue of the internationally renowned scientific journal Nature. This article was prepared by Drug Week editors from staff and other reports. Copyright 2005, Drug Week via NewsRx.com.
Source: Drug Week (2005-11-18)
|
